Order Article Reprints

Schneeweiss-Gleixner M, Filik Y, Stefanzl G, Berger D, Sadovnik I, Bauer K, Smiljkovic D, Eisenwort G, Witzeneder N, Greiner G, et al. CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V⁺ Neoplastic Mast Cells. Cancers. 2022; 14(13):3070. https://doi.org/10.3390/cancers14133070

Schneeweiss-Gleixner, Mathias, Yüksel Filik, Gabriele Stefanzl, Daniela Berger, Irina Sadovnik, Karin Bauer, Dubravka Smiljkovic, Gregor Eisenwort, Nadine Witzeneder, Georg Greiner, and et al. 2022. "CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V⁺ Neoplastic Mast Cells" Cancers 14, no. 13: 3070. https://doi.org/10.3390/cancers14133070

Schneeweiss-Gleixner, M., Filik, Y., Stefanzl, G., Berger, D., Sadovnik, I., Bauer, K., Smiljkovic, D., Eisenwort, G., Witzeneder, N., Greiner, G., Hoermann, G., Schiefer, A.-I., Schwaab, J., Jawhar, M., Reiter, A., Sperr, W. R., Arock, M., Valent, P., & Gleixner, K. V. (2022). CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V⁺ Neoplastic Mast Cells. Cancers, 14(13), 3070. https://doi.org/10.3390/cancers14133070